Logo image of MIGI

MAWSON INFRASTRUCTURE GROUP (MIGI) Stock Fundamental Analysis

NASDAQ:MIGI - Nasdaq - US57778N3070 - Common Stock - Currency: USD

0.5671  -0.03 (-5.48%)

After market: 0.56 -0.01 (-1.25%)

Fundamental Rating

2

Taking everything into account, MIGI scores 2 out of 10 in our fundamental rating. MIGI was compared to 284 industry peers in the Software industry. MIGI has a bad profitability rating. Also its financial health evaluation is rather negative. MIGI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MIGI has reported negative net income.
MIGI had a positive operating cash flow in the past year.
In the past 5 years MIGI always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: MIGI reported negative operating cash flow in multiple years.
MIGI Yearly Net Income VS EBIT VS OCF VS FCFMIGI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M -40M -60M -80M -100M

1.2 Ratios

MIGI has a Return On Assets of -89.75%. This is amonst the worse of the industry: MIGI underperforms 90.22% of its industry peers.
Industry RankSector Rank
ROA -89.75%
ROE N/A
ROIC N/A
ROA(3y)-47.27%
ROA(5y)-126.61%
ROE(3y)-104.76%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MIGI Yearly ROA, ROE, ROICMIGI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

1.3 Margins

MIGI's Gross Margin of 35.22% is on the low side compared to the rest of the industry. MIGI is outperformed by 79.71% of its industry peers.
The Profit Margin and Operating Margin are not available for MIGI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MIGI Yearly Profit, Operating, Gross MarginsMIGI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

MIGI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MIGI has been increased compared to 1 year ago.
The number of shares outstanding for MIGI has been increased compared to 5 years ago.
MIGI has a worse debt/assets ratio than last year.
MIGI Yearly Shares OutstandingMIGI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
MIGI Yearly Total Debt VS Total AssetsMIGI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M

2.2 Solvency

Based on the Altman-Z score of -6.94, we must say that MIGI is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -6.94, MIGI is not doing good in the industry: 87.32% of the companies in the same industry are doing better.
MIGI has a debt to FCF ratio of 6.58. This is a slightly negative value and a sign of low solvency as MIGI would need 6.58 years to pay back of all of its debts.
MIGI's Debt to FCF ratio of 6.58 is in line compared to the rest of the industry. MIGI outperforms 52.90% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.58
Altman-Z -6.94
ROIC/WACCN/A
WACC8.21%
MIGI Yearly LT Debt VS Equity VS FCFMIGI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M -100M

2.3 Liquidity

MIGI has a Current Ratio of 0.39. This is a bad value and indicates that MIGI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.39, MIGI is not doing good in the industry: 95.29% of the companies in the same industry are doing better.
A Quick Ratio of 0.39 indicates that MIGI may have some problems paying its short term obligations.
MIGI's Quick ratio of 0.39 is on the low side compared to the rest of the industry. MIGI is outperformed by 94.93% of its industry peers.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.39
MIGI Yearly Current Assets VS Current LiabilitesMIGI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.71% over the past year.
Looking at the last year, MIGI shows a very strong growth in Revenue. The Revenue has grown by 25.47%.
EPS 1Y (TTM)7.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.59%
Revenue 1Y (TTM)25.47%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%8.68%

3.2 Future

MIGI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.27% yearly.
The Revenue is expected to grow by 56.13% on average over the next years. This is a very strong growth
EPS Next Y31.56%
EPS Next 2Y42.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year49.18%
Revenue Next 2Y56.13%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

MIGI Yearly Revenue VS EstimatesMIGI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
MIGI Yearly EPS VS EstimatesMIGI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MIGI. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 6.18, which indicates a rather cheap valuation of MIGI.
Based on the Price/Forward Earnings ratio, MIGI is valued cheaply inside the industry as 98.19% of the companies are valued more expensively.
MIGI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.68.
Industry RankSector Rank
PE N/A
Fwd PE 6.18
MIGI Price Earnings VS Forward Price EarningsMIGI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of MIGI indicates a rather cheap valuation: MIGI is cheaper than 99.64% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.17
EV/EBITDA N/A
MIGI Per share dataMIGI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

MIGI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MIGI's earnings are expected to grow with 42.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.27%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MIGI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAWSON INFRASTRUCTURE GROUP

NASDAQ:MIGI (2/21/2025, 8:00:01 PM)

After market: 0.56 -0.01 (-1.25%)

0.5671

-0.03 (-5.48%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-11 2024-11-11/amc
Earnings (Next)03-31 2025-03-31/amc
Inst Owners6.69%
Inst Owner Change-36.92%
Ins Owners12.57%
Ins Owner Change-1.14%
Market Cap10.61M
Analysts43.33
Price Target3.06 (439.59%)
Short Float %2.28%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.9%
Min Revenue beat(2)-18.66%
Max Revenue beat(2)-9.15%
Revenue beat(4)2
Avg Revenue beat(4)7.03%
Min Revenue beat(4)-18.66%
Max Revenue beat(4)40.89%
Revenue beat(8)3
Avg Revenue beat(8)-6.42%
Revenue beat(12)4
Avg Revenue beat(12)-3.64%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-175%
EPS NQ rev (3m)-175%
EPS NY rev (1m)0%
EPS NY rev (3m)-58.64%
Revenue NQ rev (1m)-5.16%
Revenue NQ rev (3m)-5.16%
Revenue NY rev (1m)0%
Revenue NY rev (3m)17.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.18
P/S 0.18
P/FCF 3.17
P/OCF 1.97
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.83
EYN/A
EPS(NY)0.09
Fwd EY16.19%
FCF(TTM)0.18
FCFY31.52%
OCF(TTM)0.29
OCFY50.71%
SpS3.11
BVpS-0.08
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -89.75%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.22%
FCFM 5.74%
ROA(3y)-47.27%
ROA(5y)-126.61%
ROE(3y)-104.76%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.58
Debt/EBITDA N/A
Cap/Depr 7.94%
Cap/Sales 3.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.39
Quick Ratio 0.39
Altman-Z -6.94
F-Score4
WACC8.21%
ROIC/WACCN/A
Cap/Depr(3y)350.74%
Cap/Depr(5y)N/A
Cap/Sales(3y)133.9%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.59%
EPS Next Y31.56%
EPS Next 2Y42.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.47%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%8.68%
Revenue Next Year49.18%
Revenue Next 2Y56.13%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year120.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y103.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-86.46%
OCF growth 3YN/A
OCF growth 5YN/A